Etoricoxib is a synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.

Product information

CAS Number: 202409-33-4

Molecular Weight: 358.84

Formula: C18H15ClN2O2S

Synonym:

Arcoxia

MK-663

MK-0663

Chemical Name: 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-2,3'-bipyridine

Smiles: CC1=CC=C(C=N1)C1=NC=C(Cl)C=C1C1C=CC(=CC=1)S(C)(=O)=O

InChiKey: MNJVRJDLRVPLFE-UHFFFAOYSA-N

InChi: InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.